Using Penalised Logistic Regression to Fine Map HLA Variants for Rheumatoid Arthritis

Grants

Funding Acknowledgements

Special thanks are due to the participants in our study. The authors would also like to thank Mike Binks (GlaxoSmithKline UK), Marion Dickson (GlaxoSmithKline UK), Doug Montgomery (GlaxoSmithKline UK) and Gerry Wilson (University of Sheffield) for their support, as well as Clive Hoggart (Imperial College London) for help with implementation of the HyperLASSO.